Kansas City Urology Care is now an Exclusive Provider of PROVENGE

Kansas City Urology Care, P.A. – Kansas City’s Premier Center for Urology Care
Kansas City Urology Care, the premier center for urology care, is now an exclusive provider of PROVENGE, an innovative treatment option for advanced prostate cancer.

 

Overland Park, Kansas – February 10, 2017 – Prostate Cancer is the most common cancer in the United States and can be tricky to treat because of the way it spreads around the body. Recently, a team of immunotherapy specialists has developed a new treatment named “PROVENGE” which is a prescription medicine that is used to treat certain patients with advanced prostate cancer. Kansas City Urology Care is now an exclusive provider of PROVENGE, the first approved immunotherapy for advanced prostate cancer treatment in Kansas City.

A statement released by Kansas City Urology Care says, “We are proud to be an exclusive provider of PROVENGE in Kansas City. PROVENGE is the first therapeutic cancer vaccine to receive approval from the U.S. FDA. For patients with advanced prostate cancer, PROVENGE is an immunotherapy treatment that utilizes the power of the patient’s own immune system to identify and target prostate cancer cells. PROVENGE is available for patients being treated at Kansas City Urology Care as part of our standard of care regimen.”

Kansas City Urology Care, the premier center for urology care has the combined skill and experience to bring you the highest quality urologic care. The team of urologists offers expertise in providing minimally invasive treatments for diseases of the prostate, urinary incontinence, pediatric concerns, kidney stone removal, and all other urologic concerns in multiple locations across the metro area.

While explaining about the treatment, the media person stated, “PROVENGE immunotherapy treatment typically takes one month to be administered, and is given in three intravenous infusions every two weeks. Each dose of PROVENGE is given about three days after the patient’s cell collection procedure. Appointments will take approximately two hours, with the infusion being done by I.V. in about an hour. Patients will be asked to stay in the doctor’s office for at least 30 minutes after the infusion.”

The media person concluded by adding, “To find out more about PROVENGE Immunotherapy and if you are a candidate, please call our specialists at Kansas City Urology Care 913.341.7985.”


Video Link: http://www.youtube.com/embed/n3SmrZROiN8

About Kansas City Urology Care:

PROVENGE is the first approved immunotherapy for advanced prostate cancer and Kansas City Urology Care is now an exclusive provider.

Distributed by Cancer Medical Review

Media Contact
Company Name: Cancer Medical Review
Contact Person: Pete Jameson
Email: kcurologycom@gmail.com
Phone: 913 341 7985
Address:10701 Nall Avenue, Suite 100
City: Overland Park
State: Kansas
Country: United States
Website: http://www.kcurology.com/